November 2023

First US patient treated with Medtronic’s FDA-approved renal denervation system ()
‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful ()
Johnson & Johnson acquires medical device company behind new LAA technology for $400M ()
Cardiologist receives $7M for 5-year study to boost care for heart failure patients ()
Avidity Biosciences inks drug discovery deal worth up to $2.3B with industry heavyweight ()
Robotic-assisted CABG reduces healthcare costs, primarily thanks to shorter hospital stays ()
New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months ()
Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR? ()
Medtronic debuts new FDA-cleared LAA exclusion device ()
FDA announces recall of infusion sets due to defect that puts diabetes patients at risk ()
Mediterranean diet improves cardiovascular health of middle-aged women ()
Bayer ends blood thinner trial early due to lack of efficacy ()
ADHD medications associated with heightened CVD risk ()
Sensitivity to dairy products, other foods linked to higher risk of death from heart disease ()
Medtronic gains 2 key approvals for its ablation portfolio ()
Deep learning in cardiovascular imaging: 4 key takeaways for cardiologists ()
Smartphone app helps TAVR patients avoid major complications ()
FDA clears AI-powered image reconstruction technology for cardiac CT scanners ()
FDA approves another renal denervation system for hypertension ()
Gene-editing therapy lowers cholesterol in high-risk heart patients—one dose could potentially last decades ()
Cardiologists may want to rethink how they track prosthesis-patient mismatch after TAVR ()
Daily marijuana use increases heart failure risk by 34% ()
ChatGPT struggles with echocardiography, but still shows potential to help cardiology trainees ()
The expanding scope of FDG-PET in nuclear cardiac imaging ()
CVD deaths have increased dramatically, undoing years of progress ()
TAVR linked to favorable outcomes for asymptomatic and minimally symptomatic patients—but is it necessary? ()
Cardiologist reprimanded for performing surgery after testing positive for COVID-19 ()
A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes ()
Fully bioresorbable stents boost care for CLI patients in LIFE-BTK trial ()
The future of cardiology: 5 potentially game-changing AI studies from AHA 2023 ()
PCI benefits patients with stable chest pain, late-breaking data confirm ()
Shockwave C²⁺ Now Available in the U.S. ()
10 ways to improve care for in-hospital cardiac arrest ()
Intrepid transfemoral transcatheter mitral valve shows favorable results after 1 year ()
TAVR utilization skyrocketed over 5-year period, improving survival for older AS patients ()
Cardiologists develop new way to evaluate heart risks—kidney function, metabolic health included for first time ()
AI specialists raise $80M to ramp up commercialization of imaging analysis software ()
Ross procedure still linked to ‘excellent’ outcomes as patients enter third decade after surgery ()
PHOTO GALLERY: Interventional cardiology technologies at TCT 2023 ()
Cardiologist arrested in undercover operation targeting sex predators ()
FDA approves diabetes drug tirzepatide for chronic weight management under new name ()
iFR and FFR are equal, new long-term analysis confirms ()
CMS increases reimbursement for AI-powered heart failure platform ()
FDA approves first renal denervation system for uncontrolled hypertension ()
American Heart Association ‘enthusiastically’ joins other cardiology groups in push for new, independent medical board ()
ChatGPT tackles hypertension: Popular AI model a helpful resource for patients with high blood pressure ()
FDA announces Class I recall of nearly 2,000 catheter kits ()
AI model for predicting sudden cardiac death more accurate than expected ()
Private equity-backed pharmaceutical company acquires stroke drug from Bayer ()
Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients ()
Key trends in transcatheter tricuspid and mitral valve technologies ()
TAVR or SAVR? Where things stand now, from a surgeon's perspective ()
CMS increases reimbursement for CVRx’s implantable Barostim device for heart failure ()
Cardiologists, heart surgeons and imaging experts push for changes that could prevent ‘permanent and unjustifiable Medicare cuts’ ()
Next-gen RF catheter from Biosense Webster improves QOL in patients with paroxysmal AFib ()
IVUS-guided PCI boosts 2-year survival, reduces need for bypass surgery ()
TAVR and LAAO at the same time? Samir Kapadia breaks down the WATCH-TAVR trial ()
FDA grants breakthrough device designation to AI-powered, retinal imaging-based CVD assessments ()
TAVR patients with cancer face higher risks of hospital readmission, serious bleeding ()
Second patient in history to receive a pig heart transplant dies after 6 weeks ()
IVL gains higher level of reimbursement with one of biggest coding updates for PCI in decades ()